A pioneering test enabling breast cancer patients to find out their chances of recovery was unveiled by scientists.
New technology will predict with 80% accuracy a sufferer's chance of recovering, doctors claim.
The tool analyses networks of proteins in breast cancer tumours to determine a patient's best treatment options.
The breakthrough by doctors in Canada was welcomed by UK cancer charities.
Ed Yong, from Cancer Research UK, said: "Not all breast cancers are the same. By working out the differences between them at a molecular level, techniques like these could allow breast cancer patients to receive more personalised treatment from their doctor, but there's still a long way to go before we get to that point."
Analysis of more than 350 patients found those who survive breast cancer have a different organisation of the network of proteins within tumour cells.
The new testing tool, named DyNeMo, can be used to predict the outcome in a newly diagnosed breast cancer patient to assist clinicians in making informed decisions on treatment, scientists at Mount Sinai Hospital said.
Dr Jeff Wrana, writing in the journal Nature Biotechnology, said: "Our hope with this technology is to eventually provide individualised analysis to breast cancer patients and their oncologists so that they are better informed and empowered to select a treatment best suited to them."
The study was led by the Mount Sinai Hospital team and co-authored by researchers at the University of Toronto plus the London-based Institute for Cancer Research.
Dr Jim Woodgett added: "This research brings us one step closer to delivering individualised medicine in which healthcare professionals will be able to provide more accurate and personalised diagnoses and treatments."
Copyright Press Association
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.